These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 12712852

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Predictors of hematological abnormalities in patients with chronic hepatitis C treated with interferon and ribavirin.
    Nachnani JS, Rao GA, Bulchandani D, Pandya PK, Alba LM.
    Ann Hematol; 2010 Feb; 89(2):121-5. PubMed ID: 19565241
    [Abstract] [Full Text] [Related]

  • 5. HLA class I B44 is associated with sustained response to interferon + ribavirin therapy in patients with chronic hepatitis C.
    Romero-Gómez M, González-Escribano MF, Torres B, Barroso N, Montes-Cano MA, Sánchez-Muñoz D, Núñez-Roldan A, Aguilar-Reina J.
    Am J Gastroenterol; 2003 Jul; 98(7):1621-6. PubMed ID: 12873589
    [Abstract] [Full Text] [Related]

  • 6. Ribavirin in the treatment of hepatitis C.
    Abonyi ME, Lakatos PL.
    Anticancer Res; 2005 Jul; 25(2B):1315-20. PubMed ID: 15865084
    [Abstract] [Full Text] [Related]

  • 7. Review article: predicting response in hepatitis C virus therapy.
    Mihm U, Herrmann E, Sarrazin C, Zeuzem S.
    Aliment Pharmacol Ther; 2006 Apr 15; 23(8):1043-54. PubMed ID: 16611264
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Treatment of chronic hepatitis C in patients not responding to interferon].
    Moreno Monteagudo JA, García Buey L, Moreno Otero R.
    Gastroenterol Hepatol; 2000 Feb 15; 23 Suppl 1():51-6. PubMed ID: 11968345
    [No Abstract] [Full Text] [Related]

  • 16. [Treatment strategies for viral hepatitis].
    Matsushima T.
    Hokkaido Igaku Zasshi; 2002 Mar 15; 77(2):133-5. PubMed ID: 11968844
    [No Abstract] [Full Text] [Related]

  • 17. [Chronic viral hepatitis C: current therapy and perspectives].
    Couzigou P, De Ledinghen V, Foucher J.
    Gastroenterol Clin Biol; 2001 Apr 15; 25(4 Suppl):B135-42. PubMed ID: 11449154
    [No Abstract] [Full Text] [Related]

  • 18. Pediatric hepatitis C infection: to treat or not to treat...what's the best for the child?
    Serranti D, Buonsenso D, Ceccarelli M, Gargiullo L, Ranno O, Valentini P.
    Eur Rev Med Pharmacol Sci; 2011 Sep 15; 15(9):1057-67. PubMed ID: 22013729
    [Abstract] [Full Text] [Related]

  • 19. Treatment of chronic hepatitis C in hereditary spherocytosis.
    Khokhar N.
    Am J Gastroenterol; 2001 Jun 15; 96(6):1949-50. PubMed ID: 11419867
    [No Abstract] [Full Text] [Related]

  • 20. [Treatment of hepatitis C: therapeutic management].
    Bourliere M.
    Gastroenterol Clin Biol; 2008 May 15; 32(5 Pt 2):S166-71. PubMed ID: 18482813
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.